RGS2 and irritable bowel syndrome: Noticeably, IBS-exo treatment caused an obvious downregulation of RGS2 at mRNA and protein levels in HT-29 cells, which was abrogated by transfection with the miR-148b-5p inhibitor (p value < 0.001, Figures 3(c) and 3(d)).